Synthetic Cannabinoids (K2 Spice) with Confirmation
Synonyms |
|
||||||||
Cerner Name |
|||||||||
Clinical Info |
Detect use of synthetic cannabinoid drugs |
||||||||
Specimen Sources |
Bladder Kidney, Left Kidney, Right Ureter, Left Ureter, Right Urine, Catheter Urine, Clean Catch |
||||||||
Specimen Types |
Urine |
||||||||
Specimen Volume |
10 mL random Urine (5 mL min) |
||||||||
Container |
Urine Random |
||||||||
Collection Instructions |
Container/Tube: Sterile urine container |
||||||||
Transport Instructions |
Refrigerated |
||||||||
Specimen Stability |
|||||||||
Methodology |
Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS) |
||||||||
Days Performed |
|
||||||||
Performing Laboratories |
Medtox Laboratories, Inc |
||||||||
CPT |
80307 |
||||||||
PDM |
5589042 |
||||||||
Results |
|
||||||||
Result Interpretation
Negative
Qualitative synthetic cannabinoid analysis includes metabolites of the following: AB-CHMINACA, AB-FUBINACA, AB-PINACA, F-AB-PINACA, ADBICA, 5F-ADBICA, ADB-PINACA, 5F-ADB-PINACA, AKB-48, 5CI-AKB-48, 5F-AKB-48, AM2201, AM694, BB-22, BB-22 hydroxyquinolines, JWH-018, JWH-073, JWH-122, JWH-250, MAB-CHMINACA, MAM-2201, PB-22, PB-22 hydroxyquinolines, 5F-PB-22, 5F-PB-22 hydroxyquinolines, UR-144, XLR-11 Screening threshold: 1.0 ng/mL Synthetic Cannabinoid Confirmation analysis includes: AB-CHMINACA: AB-CHMINACA Butanoic Acid AB-CHMINACA Hydroxycyclohexyl AB-FUBINACA: AB-FUBINACA Oxobutanoic Acid AB-PINACA: AB-PINACA Pentanoic Acid F-AB-PINACA: AB-PINACA Pentanoic Acid ADBICA: ADBICA N-(4-hydroxypentyl) and ADBICA Pentanoic Acid 5F-ADBICA: ADBICA Pentanoic Acid ADB-PINACA: ADB-PINACA Pentanoic Acid 5F-ADB-PINACA: ADB-PINACA Pentanoic Acid AKB-48: AKB-48 N-Pentanoic Acid 5Cl-AKB-48: AKB-48 N-Pentanoic Acid 5F-AKB-48: AKB-48 N-Pentanoic Acid AM2201: JWH-018 N-Pentanoic Acid AM694: AM694 N-(5-hydroxypentyl) BB-22: BB-22 3-Carboxyindole BB-22 hydroxyquinolines: BB-22 3-Carboxyindole JWH-018: JWH-018 N-Pentanoic Acid JWH-073: JWH-073 N-Butanoic Acid JWH-122: MAM-2201 N-Pentanoic Acid JWH-250: JWH-250 N-(5-Carboxypentyl) MAB-CHMINACA: MAB-CHMINACA Butanoic Acid MAM-2201: MAM-2201 N-Pentanoic Acid PB-22: PB-22 3-Carboxyindole PB-22 hydroxyquinolines: PB-22 3-Carboxyindole 5F-PB-22: 5F-PB-22 3-Carboxyindole 5F-PB-22-hyroxyquinolines: 5F-PB-22 3-Carboxyindole UR-144: UR-144 N-Pentanoic Acid XLR-11: XLR-11 N-(4-Hydroxypentyl) and UR-144 N-Pentanoic Acid Metabolites may not be unique to the listed parent compounds as related compounds may have a common metabolic pathway. Screening threshold: 1.0 ng/mL Confirmation threshold: 1.0 ng/mL Analysis performed by Liquid Chromatography with Tandem Mass Spectrometry (LC/MS/MS). This test was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the Food and Drug Administration. |
|||||||||
Forms |
|
||||||||

